对怀疑HFpEF的老年患者的方法
1Division of Cardiovascular Medicine Indiana University School of Medicine, Indianapolis.
The American journal of medicine
|August 15, 2025
概括
运动限制的老年患者可能患有心力衰竭与保存的喷射分数 (HFpEF). 对等症状的早期尿液治疗可以预防HFpEF的发展.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
背景情况:
- 许多老年人出现呼吸障碍,限制了运动耐受性和暗示心力衰竭的症状,并保留了喷射分数 (HFpEF).
- 尽管没有诊断的H2FPEF得分,但存在HFpEF (55-75%) 的显著概率,通常伴有依赖性胀或高血压.
- 症状经常被错误地归因于衰老,肥胖或脱离条件,延迟了HFpEF诊断和治疗.
研究的目的:
- 为了突出HFpEF的低诊断在老年人有运动性呼吸障碍和.
- 为怀疑HFpEF提出主动治疗方法,与管理高的LDL胆固醇进行并行.
- 提倡使用利尿剂进行早期干预,以控制症状,并可能预防HFpEF进展.
主要方法:
- 对老年人群中HFpEF的当前数据和临床观察的审查.
- 对当前HFpEF评估工具的诊断挑战和局限性的分析.
- 对心血管风险因素的治疗策略的比较及其对疑似HFpEF的适用性.
主要成果:
- 疲劳性呼吸障碍和外周胀是敏感的,但不是HFpEF的特定指标.
- 利尿疗法在减少心力衰竭发生率和复发方面表现出有效性,在已建立的HFpEF.
- 患者怀疑HFpEF,即使没有确定的诊断,共享风险档案与条件主动管理.
结论:
- 老年患者患有不明原因的呼吸不良和水需要考虑HFpEF.
- 积极管理,包括对或高血压的轻度利尿剂,对于疑似HFpEF可能是有益的.
- 这种方法反映了用于高脂血症的基于风险的治疗模式,旨在预防疾病的发展或进展.
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
01:30Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:29Heart Failure II: Pathophysiology
41
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27